Alkermes

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.

About ALKS

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.

CEO

Richard F. Pops

CEORichard F. Pops

Employees

1,800

Employees1,800

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2011

Founded2011

Employees

1,800

Employees1,800

ALKS Key Statistics

Market cap

4.80B

Market cap4.80B

Price-Earnings ratio

14.43

Price-Earnings ratio14.43

Dividend yield

—

Dividend yield—

Average volume

1.72M

Average volume1.72M

High today

$29.39

High today$29.39

Low today

$28.42

Low today$28.42

Open price

$29.26

Open price$29.26

Volume

1.47M

Volume1.47M

52 Week high

$36.45

52 Week high$36.45

52 Week low

$25.17

52 Week low$25.17

Stock Snapshot

The current Alkermes(ALKS) stock price is $28.50, with a market capitalization of 4.8B. The stock trades at a price-to-earnings (P/E) ratio of 14.43.

On 2025-12-13, Alkermes(ALKS) stock traded between a low of $28.42 and a high of $29.39. Shares are currently priced at $28.50, which is +0.3% above the low and -3.0% below the high.

The Alkermes(ALKS)'s current trading volume is 1.47M, compared to an average daily volume of 1.72M.

In the last year, Alkermes(ALKS) shares hit a 52-week high of $36.45 and a 52-week low of $25.17.

Analyst ratings

81%

of 16 ratings

Buy

81.3%

Hold

18.8%

Sell

People also own

Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.